Free Trial

ENDRA Life Sciences (NDRA) Earnings Date, Estimates & Call Transcripts

ENDRA Life Sciences logo
$5.07 +0.36 (+7.64%)
(As of 11/20/2024 ET)

ENDRA Life Sciences Latest Earnings Summary

Latest Q2 2024
Earnings Date
Aug. 14Estimated
Actual EPS
(Aug. 14)
-$140.00 Missed By -$17.50
Consensus EPS
(Aug. 14)
-$122.50

ENDRA Life Sciences posted Q2 2024 earnings on August 14, 2024, reporting an EPS of -$140.00, which missed analysts' consensus estimates of -$122.50 by $17.50. With a trailing EPS of -$901.15, ENDRA Life Sciences' earnings are expected to grow next year, from ($387.41) to ($311.54) per share.

Get ENDRA Life Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ENDRA Life Sciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NDRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NDRA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ENDRA Life Sciences Analyst EPS Estimates

Current Year EPS Consensus Estimate:($387.41) EPS
Next Year EPS Consensus Estimate: ($311.54) EPS

ENDRA Life Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
8/14/2024Q2 2024-$122.50-$140.00 -$17.50-$0.08--  
5/14/2024Q1 2024--$22,750.00 -$22,750.00-$0.26--  
3/28/2024Q4 2023--$14,875.00 -$14,875.00-$0.17--
11/14/2023Q3 2023--$700.00 -$700.00-$0.40--  
8/14/2023Q2 2023--$752.50 -$752.50-$0.43--  
5/15/2023Q1 2023-$1,785.00-$1,627.50+$157.50-$0.93--  
3/14/2023Q4 2022-$70,000.00-$91,000.00 -$21,000.00-$1.04--  

ENDRA Life Sciences Earnings - Frequently Asked Questions

ENDRA Life Sciences (NASDAQ:NDRA) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on NDRA's earnings history.

In the previous quarter, ENDRA Life Sciences (NASDAQ:NDRA) missed the analysts' consensus estimate of ($122.50) by $17.50 with a reported earnings per share (EPS) of ($140.00). Learn more on analysts' earnings estimate vs. NDRA's actual earnings.

The conference call transcript for ENDRA Life Sciences's latest earnings report can be read online.
Read Transcript

ENDRA Life Sciences (NASDAQ:NDRA) has a recorded net income of -$10.06 million. NDRA has generated -$901.15 earnings per share over the last four quarters.

ENDRA Life Sciences's earnings are expected to grow from ($387.41) per share to ($311.54) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:NDRA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners